实用医学杂志 ›› 2021, Vol. 37 ›› Issue (17): 2214-2218.doi: 10.3969/j.issn.1006⁃5725.2021.17.009

• 临床研究 • 上一篇    下一篇

宫颈癌患者癌组织中IL⁃33表达水平与临床病理特征及预后的相关性

苏博1 闫振宇1 郝尚辉2 孙丽3 忽平3 高毅4   

  1. 南阳市中心医院1 病理科,3 妇产科,4 麻醉科(河南南阳 473000);2 新乡医学院第一附属医院妇产科 (河南新乡 453000)

  • 出版日期:2021-09-10 发布日期:2021-09-10
  • 通讯作者: 闫振宇 E⁃mail:yanzy0418@163.com
  • 基金资助:

    河南省2018年科技发展计划(编号:182102311190)

Association of expression of IL⁃33 with clinic⁃pathological features and prognosis in patients with cervical cancer tissues

SU Bo*,YAN Zhenyu,HAO Shanghui,SUN Li,HU Ping,GAO Yi.   

  1. Department of Pathology Nanyang Central Hospital,Nanyang 473000,China

  • Online:2021-09-10 Published:2021-09-10
  • Contact: YAN Zhenyu E⁃mail:yanzy0418@163.com

摘要:

目的 探讨宫颈癌组织中IL⁃33表达水平与临床病理特征及预后的关系。方法 纳入2016 1 月至 2017 12 月于我院妇产科确诊的 184 例宫颈癌患者作为研究对象,免疫组化方法检测癌组织和癌 旁组织中 IL⁃33 表达水平。分析宫颈癌组织中 IL⁃33 表达水平与临床病理特征的关系,采用 Cox 回归分析 宫颈癌患者预后的影响因素。结果 宫颈癌旁组织中 IL⁃33 均为低表达,癌组织中 IL⁃33 高表达 126 例,低表达 58 例,主要表达于细胞浆中,呈棕黄色及棕褐色颗粒。宫颈癌组织中 IL⁃33 表达水平在分化程度、肌层浸润深度、FIGO 分期和淋巴结转移上差异有统计学意义(P < 0.05)。本研究中宫颈癌患者复发或死亡 141 例,未复发或死亡 43 例,其中复发或死亡患者癌组织中 IL⁃33 高表达 103 例,低表达 38 例,未复发或 死亡患者癌组织中 IL⁃33 高表达 23 例,低表达 20 例,预后不良与预后良好组患者癌组织中 IL⁃33 表达水平 存在差异有统计学意义(P = 0.016)。肌层浸润深度、FIGO 分期、淋巴结转移和 IL⁃33 高表达是影响宫颈癌 患者不良预后的危险因素(P < 0.001)。结论 宫颈癌组织中 IL⁃33 呈现高表达,IL⁃33 高表达与宫颈癌患 者不良预后密切相关

关键词:

宫颈癌, IL?33, 临床病理特征, 预后, 标志物 ,

Abstract:

Objective To investigate the relationship between IL⁃33 expression level and clinic⁃pathological features and prognosis in patients with cervical cancer. Methods A total of 184 patients with cervical cancer in the Department of Gynecology and Obstetrics of our hospital from January 2016 to December 2017 were enrolled. The IL⁃33 expression in cervical cancer and adjacent tissues were detected by immunohistochemistry. The relationship between IL⁃33 expression and clinic⁃pathological characteristics in patients with cervical cancer was analyzed. The factors influencing the prognosis was analyzed by Cox proportional hazards analysis. Results The IL⁃33 expression was negative or weak in cervical adjacent tissues. There were 126 and 58 cases with high and low expression of IL⁃33 in cervical cancer tissues,respectively. IL⁃33 is mainly expressed in the cytoplasm of cells,showing brownish yellow and tan granules. The IL⁃33 expression level in cervical cancer tissues were significantly associated with the cell differentiation degree,depth of muscular invasion,FIGO stage and lymph node metastasis(P < 0.05). By the end of follow⁃up,141 cases of cervical cancer patients had recurrence or death,while 43 cases had no recurrence or death. Among them,103 cases had higher IL⁃33 expression and 38 cases had lower IL⁃33 expression in patients with recurrence or death. Another 23 cases had higher IL⁃33 expression and 20 cases had lower IL⁃33 expression in patients without recurrence or death. The expression level of IL⁃33 in cervical cancer tissues between patients with poor and good prognosis was significantly different(P = 0.016). The muscular invasion depth,FIGO stage,lymph node metastasis and higher IL ⁃ 33 expression were risk factors for poor prognosis in patients with cervical cancer (P < 0.000). Conclusions The expression level of IL⁃33 in cervical cancer tissues was higher,which is closely related to poor prognosis. 

Key words:

cervical cancer, IL?33, clinic?pathological features, prognosis, marker